Cayenne, France

Serge E Pauillac

This inventor holds 2 USPTO granted patents. Top assignee: Institut Pasteur. Active years: 1991-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Serge E Pauillac. Retrieved from https://idiyas.com/inventor/serge-e-pauillac

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1991-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Serge E Pauillac

Introduction

Serge E Pauillac is a notable inventor based in Cayenne, France. He has made significant contributions to the field of vaccine development, particularly in the fight against malaria. With a total of 2 patents, his work is recognized for its potential impact on public health.

Latest Patents

One of his latest patents is a process for preparing a vaccine against malaria. This innovative process involves at least one polypeptide extracted from a schizont form of a strain of Plasmodium that contains polypeptides antigenic to malaria. The polypeptides are recognized by immunoglobulin from a Saimiri Sciureus monkey that is resistant to the strain. The process includes several steps aimed at inducing protective antibodies against malaria. Another significant patent is an immunogenic composition for a vaccine against human malaria. This composition contains one or more polypeptides that can be extracted from a schizont form of a human-malaria parasite, such as Plasmodium falciparum. The polypeptides have a molecular weight ranging from 40,000 to 140,000 and react with protective antibodies derived from a monkey resistant to the malaria parasite. This innovative approach has the potential to protect sensitive monkeys against the parasite through in vivo transfer.

Career Highlights

Serge E Pauillac is affiliated with the prestigious Institut Pasteur, where he continues to advance his research in vaccine development. His work is crucial in addressing the challenges posed by malaria, a disease that affects millions worldwide.

Collaborations

Throughout his career, Pauillac has collaborated with esteemed colleagues, including Philippe Dubois and Jean P Dedet. These collaborations have further enriched his research and contributed to the advancement of vaccine technology.

Conclusion

Serge E Pauillac's innovative work in vaccine development showcases his commitment to combating malaria through scientific research. His contributions are vital in the ongoing efforts to improve public health and develop effective vaccines.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…